Jens Buentzel

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study

Jens Buentzel, Oliver Micke, Irenäus A. Adamietz et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 148 citations

Medicine, Oncology, Radiation Oncology +10

User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center.

Jutta Huebner, Oliver Micke, Ralph Muecke et al. · PubMed · 2014 · 123 citations

Medicine, Oncology, Clinical Medicine +6

Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology

Ralph Muecke, Lutz Schomburg, Michael Glatzel et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 115 citations

Medicine, Oncology, Radiation Oncology +11

Patients with advanced cancer and their usage of complementary and alternative medicine

Magda Paul, Brooke Davey, Bianca Senf et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database

Orlando Guntinas‐Lichius, Thomas Wendt, Jens Buentzel et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 87 citations · Full text

Medicine, Oncology, Surgery +7